Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
---|
C026114 |
2-xylene |
2-xylene results in increased expression of PRNP mRNA | increases expression | 20359517
|
C009505 |
4,4'-diaminodiphenylmethane |
4,4'-diaminodiphenylmethane results in decreased expression of PRNP mRNA | decreases expression | 18648102
|
C430898 |
AGN 194204 |
AGN 194204 results in decreased expression of PRNP mRNA | decreases expression | 16339527
|
D013196 |
Dihydrotestosterone |
Dihydrotestosterone results in decreased expression of PRNP mRNA | decreases expression | 17023530
|
D000643 |
Ammonium Chloride |
Ammonium Chloride affects the expression of PRNP mRNA | affects expression | 16483693
|
D001554 |
Benzene |
Benzene results in increased expression of PRNP mRNA | increases expression | 20359517
|
C095105 |
bexarotene |
bexarotene results in decreased expression of PRNP mRNA | decreases expression | 16648578
|
C006780 |
bisphenol A |
bisphenol A results in decreased expression of PRNP mRNA | decreases expression | 20678512
|
C006780 |
bisphenol A |
bisphenol A results in increased expression of PRNP mRNA | increases expression | 12075121
|
D020122 |
tert-Butylhydroperoxide |
tert-Butylhydroperoxide results in increased expression of PRNP mRNA | increases expression | 15336504
|
D019256 |
Cadmium Chloride |
Cadmium Chloride results in increased expression of PRNP mRNA | increases expression | 12760830
|
D009249 |
NADP |
[NADP co-treated with cupric chloride] promotes the reaction [PRNP protein binds to PRNP protein] | affects binding|affects cotreatment|increases reaction | 16990274
|
D003300 |
Copper |
Copper affects the folding of PRNP protein | affects folding | 16791441
|
D003300 |
Copper |
PRNP protein binds to Copper | affects binding | 17112476
|
D003300 |
Copper |
[PRNP protein binds to Copper] which results in increased activity of SOD1 protein | affects binding|increases activity | 17112476
|
D003300 |
Copper |
Copper binds to PRNP protein | affects binding | 17126907 16990274 17257012 16824036 16831968
|
D003300 |
Copper |
PRNP protein binds to Copper | affects binding | 17112476 16847141
|
D003300 |
Copper |
[PRNP protein binds to Copper] which results in increased activity of SOD1 protein | affects binding|increases activity | 17112476
|
D003300 |
Copper |
PRNP protein polymorphism binds to Copper | affects binding | 16847141
|
D003300 |
Copper |
Copper affects the localization of [GPC1 protein co-treated with PRNP protein] | affects cotreatment|affects localization | 16923158
|
D003300 |
Copper |
Copper affects the reaction [LRP1 protein results in increased uptake of PRNP protein] | affects reaction|increases uptake | 17155929
|
D003300 |
Copper |
Copper binds to PRNP protein | affects binding | 16990274 16698781
|
D003300 |
Copper |
Copper results in increased uptake of PRNP protein | increases uptake | 17155929
|
D003300 |
Copper |
PRNP protein binds to Copper | affects binding | 16787422 17112476
|
D003300 |
Copper |
PRNP protein results in decreased susceptibility to Copper | decreases response to substance | 16787422
|
D003300 |
Copper |
Copper binds to and affects the folding of PRNP protein polymorphism | affects binding|affects folding | 16777497
|
D003300 |
Copper |
[Copper binds to PRNP protein polymorphism] which binds to thioflavin T | affects binding | 16777497
|
D003300 |
Copper |
Copper results in increased degradation of PRNP protein | increases degradation | 16640559
|
D003300 |
Copper |
Phosphatidylinositols promotes the reaction [Copper results in increased degradation of PRNP protein] | increases degradation|increases reaction | 16640559
|
D003300 |
Copper |
PRNP protein results in increased reduction of Copper | increases reduction | 16640559
|
D003300 |
Copper |
Copper affects the localization of and affects the degradation of PRNP protein | affects degradation|affects localization | 16545469
|
D003300 |
Copper |
Copper binds to PRNP protein | affects binding | 16925523
|
D003300 |
Copper |
PRNP protein binds to and results in decreased activity of Copper | affects binding|decreases activity | 17059225
|
D019327 |
Copper Sulfate |
PRNP protein binds to Copper Sulfate | affects binding | 16847141
|
D019327 |
Copper Sulfate |
PRNP protein polymorphism binds to Copper Sulfate | affects binding | 16847141
|
D019327 |
Copper Sulfate |
PRNP protein binds to Copper Sulfate | affects binding | 16787422
|
D019327 |
Copper Sulfate |
PRNP protein results in decreased susceptibility to Copper Sulfate | decreases response to substance | 16787422
|
C029892 |
cupric chloride |
[NADP co-treated with cupric chloride] promotes the reaction [PRNP protein binds to PRNP protein] | affects binding|affects cotreatment|increases reaction | 16990274
|
C029892 |
cupric chloride |
cupric chloride affects the folding of PRNP protein | affects folding | 16855791
|
D016572 |
Cyclosporine |
Cyclosporine results in increased expression of PRNP mRNA | increases expression | 20106945
|
D002945 |
Cisplatin |
PRNP protein results in decreased susceptibility to Cisplatin | decreases response to substance | 15386405
|
D004052 |
Diethylnitrosamine |
Diethylnitrosamine results in increased expression of PRNP mRNA | increases expression | 19638242
|
D002117 |
Calcitriol |
Calcitriol results in increased expression of PRNP mRNA | increases expression | 16002434
|
D004317 |
Doxorubicin |
PRNP protein results in decreased susceptibility to Doxorubicin | decreases response to substance | 15386405
|
D004997 |
Ethinyl Estradiol |
[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of PRNP mRNA | affects cotreatment|increases expression | 17942748
|
D004997 |
Ethinyl Estradiol |
Ethinyl Estradiol results in increased expression of PRNP mRNA | increases expression | 12075121
|
C004912 |
ethylbenzene |
ethylbenzene results in increased expression of PRNP mRNA | increases expression | 20359517
|
D005047 |
Etoposide |
PRNP protein results in decreased susceptibility to Etoposide | decreases response to substance | 15386405
|
D005472 |
Fluorouracil |
PRNP protein results in decreased susceptibility to Fluorouracil | decreases response to substance | 15386405
|
D019833 |
Genistein |
Genistein results in increased expression of PRNP mRNA | increases expression | 12075121
|
D006861 |
Hydrogen Peroxide |
Hydrogen Peroxide results in increased expression of PRNP mRNA | increases expression | 12419474
|
D008070 |
Lipopolysaccharides |
Lipopolysaccharides results in increased expression of PRNP mRNA | increases expression | 19339665
|
D008070 |
Lipopolysaccharides |
methyldithiocarbamate inhibits the reaction [Lipopolysaccharides results in increased expression of PRNP mRNA] | decreases reaction|increases expression | 19339665
|
C008435 |
methyldithiocarbamate |
methyldithiocarbamate inhibits the reaction [Lipopolysaccharides results in increased expression of PRNP mRNA] | decreases reaction|increases expression | 19339665
|
D008752 |
Methylene Chloride |
Methylene Chloride results in increased expression of PRNP mRNA | increases expression | 20359517
|
C008493 |
methylselenic acid |
methylselenic acid results in increased expression of PRNP mRNA | increases expression | 18548127
|
D016685 |
Mitomycin |
Mitomycin results in increased expression of PRNP mRNA | increases expression | 12760830
|
D009532 |
Nickel |
Nickel binds to PRNP protein | affects binding | 17126907
|
C014707 |
nitrosobenzylmethylamine |
nitrosobenzylmethylamine results in increased expression of PRNP mRNA | increases expression | 17616710
|
D010269 |
Paraquat |
PRNP protein results in decreased susceptibility to Paraquat | decreases response to substance | 15451062 17896796
|
D010716 |
Phosphatidylinositols |
Phosphatidylinositols promotes the reaction [Copper results in increased degradation of PRNP protein] | increases degradation|increases reaction | 16640559
|
D010716 |
Phosphatidylinositols |
Phosphatidylinositols promotes the reaction [PRNP protein binds to PRNP protein] | affects binding|increases reaction | 16640559
|
C006253 |
pirinixic acid |
pirinixic acid results in decreased expression of PRNP mRNA | decreases expression | 17426115
|
D011374 |
Progesterone |
Progesterone results in increased expression of PRNP mRNA | increases expression | 18037150
|
C017947 |
sodium arsenite |
sodium arsenite results in increased expression of PRNP mRNA | increases expression | 12760830
|
D013749 |
Tetrachlorodibenzodioxin |
[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of PRNP mRNA | affects cotreatment|increases expression | 17942748
|
D013752 |
Tetracycline |
Tetracycline binds to PRNP protein | affects binding | 10903871
|
D013752 |
Tetracycline |
Tetracycline inhibits the reaction [PRNP protein binds to PRNP protein] | affects binding|decreases reaction | 10903871
|
C009462 |
thioflavin T |
[Copper binds to PRNP protein polymorphism] which binds to thioflavin T | affects binding | 16777497
|
C009462 |
thioflavin T |
thioflavin T binds to PRNP protein | affects binding | 16777497
|
C009462 |
thioflavin T |
thioflavin T binds to PRNP protein polymorphism | affects binding | 16777497
|
C009462 |
thioflavin T |
[Zinc binds to PRNP protein polymorphism] which binds to thioflavin T | affects binding | 16777497
|
D014050 |
Toluene |
Toluene results in increased expression of PRNP mRNA | increases expression | 20359517
|
D014241 |
Trichloroethylene |
Trichloroethylene results in increased expression of PRNP mRNA | increases expression | 20359517
|
D014635 |
Valproic Acid |
Valproic Acid results in increased expression of PRNP mRNA | increases expression | 19101580
|
D014750 |
Vincristine |
PRNP protein results in decreased susceptibility to Vincristine | decreases response to substance | 15386405
|
D015032 |
Zinc |
Zinc binds to PRNP protein polymorphism | affects binding | 16777497
|
D015032 |
Zinc |
[Zinc binds to PRNP protein polymorphism] which binds to thioflavin T | affects binding | 16777497
|
Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Tetrachlorodibenzodioxin |
6.74 | 15322242 14514962 11752688 |
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Valproic Acid |
6.74 | 8875741 |
MESH:D000015 |
Abnormalities, Multiple |
|
Valproic Acid |
3.50 | 19490988 |
MESH:D000138 |
Acidosis |
|
Ammonium Chloride |
3.08 | 18287403 |
MESH:D000142 |
Acidosis, Respiratory |
|
Copper Sulfate |
5.95 | 7265320 |
MESH:D000152 |
Acne Vulgaris |
|
Ethinyl Estradiol |
3.46 | 17505938 |
MESH:D000169 |
Acrodermatitis |
|
Zinc |
4.93 | 17202136 17190629 16889938 |
MESH:D058186 |
Acute Kidney Injury |
|
Cisplatin |
3.54 | 17670903 12690470 15814532 |
MESH:D055371 |
Acute Lung Injury |
|
Lipopolysaccharides |
12.83 | 18653653 11850527 |
MESH:D055371 |
Acute Lung Injury |
|
Nickel |
12.83 | 16166738 |
MESH:D055371 |
Acute Lung Injury |
|
pirinixic acid |
12.83 | 18653653 |
MESH:D000230 |
Adenocarcinoma |
|
Cisplatin |
15.25 | 17638652 11798837 |
MESH:D000230 |
Adenocarcinoma |
|
Doxorubicin |
15.25 | 17418594 |
MESH:D000230 |
Adenocarcinoma |
|
Ethinyl Estradiol |
15.25 | 14692618 |
MESH:D000230 |
Adenocarcinoma |
|
Fluorouracil |
15.25 | 17638652 |
MESH:D000230 |
Adenocarcinoma |
|
Genistein |
15.25 | 11473722 |
MESH:D000230 |
Adenocarcinoma |
|
Vincristine |
15.25 | 19825857 |
MESH:D000236 |
Adenoma |
|
4,4'-diaminodiphenylmethane |
5.71 | 3712494 |
MESH:D000236 |
Adenoma |
|
Diethylnitrosamine |
5.71 | 6695378 10737359 |
MESH:D018248 |
Adenoma, Liver Cell |
|
Diethylnitrosamine |
14.52 | 17620307 16434500 18056438 19061943 17162532 19052882 |
MESH:D018248 |
Adenoma, Liver Cell |
|
pirinixic acid |
14.52 | 16434500 |
MESH:D018248 |
Adenoma, Liver Cell |
|
Tetrachlorodibenzodioxin |
14.52 | 16835633 |
MESH:D000310 |
Adrenal Gland Neoplasms |
|
sodium arsenite |
4.21 | 15276417 |
MESH:D018246 |
Adrenocortical Adenoma |
|
sodium arsenite |
4.42 | 17306315 16712894 |
MESH:D000382 |
Agricultural Workers' Diseases |
|
Paraquat |
3.30 | 11874814 |
MESH:D000419 |
Albuminuria |
|
Doxorubicin |
4.09 | 21441931 |
MESH:D000544 |
Alzheimer Disease |
marker/mechanism |
|
| 17192785 |
MESH:D000544 |
Alzheimer Disease |
|
Copper |
4.31 | 17119284 16866297 16886094 16410023 16325427 16962711 |
MESH:D000544 |
Alzheimer Disease |
|
Zinc |
4.31 | 16580781 16325427 16410023 17119284 |
MESH:D000550 |
Amblyopia |
|
Valproic Acid |
4.75 | 17688650 |
MESH:D000690 |
Amyotrophic Lateral Sclerosis |
|
Copper |
3.99 | 10694572 |
MESH:D000740 |
Anemia |
|
Fluorouracil |
7.31 | 16511603 15504547 17963324 |
MESH:D000740 |
Anemia |
|
Tetrachlorodibenzodioxin |
7.31 | 11748828 |
MESH:D000741 |
Anemia, Aplastic |
|
Benzene |
4.00 | 17661222 14761424 11369114 |
MESH:D018798 |
Anemia, Iron-Deficiency |
|
Copper |
4.46 | 16614410 |
MESH:D000755 |
Anemia, Sickle Cell |
|
Zinc |
4.45 | 16916123 |
MESH:D000860 |
Anoxia |
|
Copper Sulfate |
5.45 | 7265320 |
MESH:D001008 |
Anxiety Disorders |
|
Valproic Acid |
3.20 | 17497229 |
MESH:D001161 |
Arteriosclerosis |
|
Ethinyl Estradiol |
3.00 | 11256880 |
MESH:D001169 |
Arthritis, Experimental |
|
Ethinyl Estradiol |
2.36 | 15885639 |
MESH:D001249 |
Asthma |
|
Zinc |
2.80 | 17085522 |
MESH:D001321 |
Autistic Disorder |
|
Valproic Acid |
2.06 | 20603192 17507914 18396377 18985861 18940202 17688650 18177632 18558336 18775368 18316065 19460635 15238991 19232924 17157402 16609825 |
MESH:D001660 |
Biliary Tract Diseases |
|
4,4'-diaminodiphenylmethane |
4.53 | 11289319 1440618 |
MESH:D001714 |
Bipolar Disorder |
|
Valproic Acid |
2.82 | 20046352 17594078 |
MESH:D001778 |
Blood Coagulation Disorders |
|
pirinixic acid |
7.35 | 19483382 |
MESH:D001778 |
Blood Coagulation Disorders |
|
Tetrachlorodibenzodioxin |
7.35 | 12125929 |
MESH:D001836 |
Body Weight Changes |
|
2-xylene |
10.49 | 7457028 |
MESH:D001836 |
Body Weight Changes |
|
Tetrachlorodibenzodioxin |
10.49 | 15340226 |
MESH:D001848 |
Bone Diseases, Developmental |
|
Tetrachlorodibenzodioxin |
6.97 | 15746008 |
MESH:D001848 |
Bone Diseases, Developmental |
|
Valproic Acid |
6.97 | 8888407 |
MESH:D001855 |
Bone Marrow Diseases |
|
Benzene |
4.74 | 16183116 |
MESH:D019046 |
Bone Marrow Neoplasms |
|
Cisplatin |
17.56 | 14601052 |
MESH:D019046 |
Bone Marrow Neoplasms |
|
Doxorubicin |
17.56 | 14601052 |
MESH:D019046 |
Bone Marrow Neoplasms |
|
Etoposide |
17.56 | 14601052 |
MESH:D001862 |
Bone Resorption |
|
bisphenol A |
3.44 | 11985600 |
MESH:D020201 |
Brain Hemorrhage, Traumatic |
|
Progesterone |
4.85 | 17868700 |
MESH:D001930 |
Brain Injuries |
|
Progesterone |
9.50 | 15665606 15380490 15845082 |
MESH:D001930 |
Brain Injuries |
|
Zinc |
9.50 | 17109824 |
MESH:D001932 |
Brain Neoplasms |
|
Copper |
7.82 | 17079463 |
MESH:D001932 |
Brain Neoplasms |
|
Doxorubicin |
7.82 | 17150277 |
MESH:D001943 |
Breast Neoplasms |
|
Benzene |
14.87 | 11921183 17162533 |
MESH:D001943 |
Breast Neoplasms |
|
bexarotene |
14.87 | 16818667 16344269 |
MESH:D001943 |
Breast Neoplasms |
|
bisphenol A |
14.87 | 17123778 |
MESH:D001943 |
Breast Neoplasms |
|
Calcitriol |
14.87 | 11237771 |
MESH:D001943 |
Breast Neoplasms |
|
Cisplatin |
14.87 | 19526202 18382427 |
MESH:D001943 |
Breast Neoplasms |
|
Copper |
14.87 | 15986119 17079463 |
MESH:D001943 |
Breast Neoplasms |
|
Diethylnitrosamine |
14.87 | 17474063 |
MESH:D001943 |
Breast Neoplasms |
|
Doxorubicin |
14.87 | 15136595 15567936 15668708 16115903 16096432 17426702 18628466 15634643 19526202 15993339 16826403 17369602 15692762 16935488 16595493 16264153 11325840 18695136 15939500 16322301 15994142 17983394 18382427 18234424 |
MESH:D001943 |
Breast Neoplasms |
|
Etoposide |
14.87 | 16322251 |
MESH:D001943 |
Breast Neoplasms |
|
Fluorouracil |
14.87 | 15136595 18608205 16595493 19217205 16110121 16557594 18357371 |
MESH:D001943 |
Breast Neoplasms |
|
Genistein |
14.87 | 16873071 17200150 16541309 |
MESH:D001943 |
Breast Neoplasms |
|
Methylene Chloride |
14.87 | 15986119 |
MESH:D001943 |
Breast Neoplasms |
|
Nickel |
14.87 | 15986119 |
MESH:D001943 |
Breast Neoplasms |
|
Progesterone |
14.87 | 15562024 17614352 16175315 |
MESH:D001943 |
Breast Neoplasms |
|
Tetrachlorodibenzodioxin |
14.87 | 20435547 |
MESH:D001943 |
Breast Neoplasms |
|
Trichloroethylene |
14.87 | 15986119 |
MESH:D002276 |
Carcinoid Tumor |
|
Doxorubicin |
10.73 | 16051944 |
MESH:D002276 |
Carcinoid Tumor |
|
Fluorouracil |
10.73 | 16051944 |
MESH:D002277 |
Carcinoma |
|
Fluorouracil |
6.93 | 17121937 |
MESH:D002277 |
Carcinoma |
|
Tetrachlorodibenzodioxin |
6.93 | 16835633 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
4,4'-diaminodiphenylmethane |
12.60 | 7296757 3581430 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Cisplatin |
12.60 | 17982673 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Diethylnitrosamine |
12.60 | 20935162 18978308 16779866 19171122 11831363 17173139 20512989 20214788 21159647 16878318 17761372 19539802 19335982 19919837 19418558 20727157 16807293 16935385 20084675 19383236 3581430 20514400 18665156 17055752 18210153 17162532 10737359 19701751 20524982 20101231 3084413 16830150 18056438 16288022 18691550 16569478 16681979 16328049 18785209 19107877 17428255 19208518 20007298 17138121 20432363 16698587 19394651 16502159 19822196 18506893 18971187 18788625 19519916 17978847 19052882 18494052 10672840 16540662 18393292 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Doxorubicin |
12.60 | 16234567 16023760 17876044 18059187 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Fluorouracil |
12.60 | 16332177 16799960 17045692 17971768 17088986 18930000 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Genistein |
12.60 | 16924424 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
sodium arsenite |
12.60 | 16507464 17306315 15276417 |
MESH:D002278 |
Carcinoma in Situ |
|
bisphenol A |
4.51 | 17123778 |
MESH:D002289 |
Carcinoma, Non-Small-Cell Lung |
|
bexarotene |
5.25 | 16247446 |
MESH:D002289 |
Carcinoma, Non-Small-Cell Lung |
|
Cisplatin |
5.25 | 16685392 12023789 |
MESH:D002292 |
Carcinoma, Renal Cell |
|
4,4'-diaminodiphenylmethane |
13.44 | 7296757 |
MESH:D002292 |
Carcinoma, Renal Cell |
|
Doxorubicin |
13.44 | 16201981 1485588 |
MESH:D002292 |
Carcinoma, Renal Cell |
|
Fluorouracil |
13.44 | 18695887 |
MESH:D002292 |
Carcinoma, Renal Cell |
|
Vincristine |
13.44 | 16201981 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Calcitriol |
19.51 | 11237771 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Cisplatin |
19.51 | 17066447 18337622 6189445 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Doxorubicin |
19.51 | 6189445 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Fluorouracil |
19.51 | 16757204 18986760 16280240 17066447 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
sodium arsenite |
19.51 | 18572023 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Vincristine |
19.51 | 6189445 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Zinc |
19.51 | 16543248 |
MESH:D006332 |
Cardiomegaly |
|
Copper |
6.13 | 17327471 |
MESH:D006332 |
Cardiomegaly |
|
Tetrachlorodibenzodioxin |
6.13 | 16120746 18850075 18670907 |
MESH:D009202 |
Cardiomyopathies |
|
Doxorubicin |
3.21 | 18627295 17329180 17974986 17131338 17382496 17519947 15792986 15476868 16242529 16455267 17924179 16731534 16952015 16109756 16612575 16269455 16278810 17007740 15811867 16364871 16651473 15505089 17351982 17308081 17928571 |
MESH:D002311 |
Cardiomyopathy, Dilated |
|
Doxorubicin |
2.77 | 17334414 16243910 |
MESH:D002318 |
Cardiovascular Diseases |
|
Genistein |
10.34 | 16332659 |
MESH:D002318 |
Cardiovascular Diseases |
|
Hydrogen Peroxide |
10.34 | 16936243 |
MESH:D002318 |
Cardiovascular Diseases |
|
Zinc |
10.34 | 16936243 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
4,4'-diaminodiphenylmethane |
13.27 | 7505956 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Cyclosporine |
13.27 | 12371664 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Diethylnitrosamine |
13.27 | 17174075 21159647 2727394 7505956 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
sodium arsenite |
13.27 | 19524636 20056578 |
MESH:D002547 |
Cerebral Palsy |
|
Toluene |
5.37 | 9294310 |
MESH:D002659 |
Child Development Disorders, Pervasive |
|
Valproic Acid |
2.52 | 20734317 |
MESH:D018281 |
Cholangiocarcinoma |
|
Diethylnitrosamine |
7.99 | 19052882 |
MESH:D018281 |
Cholangiocarcinoma |
|
Tetrachlorodibenzodioxin |
7.99 | 16835633 |
MESH:D002779 |
Cholestasis |
|
4,4'-diaminodiphenylmethane |
16.29 | 19486331 9022650 |
MESH:D002779 |
Cholestasis |
|
Cyclosporine |
16.29 | 19486331 |
MESH:D002779 |
Cholestasis |
|
Ethinyl Estradiol |
16.29 | 16105132 11677210 17333356 15861022 17681005 16919318 17110522 |
MESH:D002779 |
Cholestasis |
|
pirinixic acid |
16.29 | 19176532 |
MESH:D002972 |
Cleft Palate |
|
Tetrachlorodibenzodioxin |
1.89 | 16354765 8697196 15668235 15340226 12621046 |
MESH:D003110 |
Colonic Neoplasms |
|
Fluorouracil |
3.50 | 17018589 17725105 18772588 16510598 17169374 15001691 17016597 17172411 16340194 17287894 |
MESH:D003110 |
Colonic Neoplasms |
|
Genistein |
3.50 | 17182828 |
MESH:D015179 |
Colorectal Neoplasms |
|
Cisplatin |
3.24 | 15273666 |
MESH:D015179 |
Colorectal Neoplasms |
|
Doxorubicin |
3.24 | 18802399 18259882 |
MESH:D015179 |
Colorectal Neoplasms |
|
Fluorouracil |
3.24 | 17401013 14970324 16524972 16303861 20501625 17255274 18802399 18288408 18448328 17594712 15148649 17016601 16282729 18383874 17695437 15289873 16331619 18949393 18509181 16391804 17094418 17454858 |
MESH:D000013 |
Congenital Abnormalities |
|
Tetrachlorodibenzodioxin |
2.66 | 17141729 14669216 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Benzene |
6.64 | 15643154 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Tetrachlorodibenzodioxin |
6.64 | 15322242 10048152 20055451 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Toluene |
6.64 | 9294310 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Valproic Acid |
6.64 | 16575769 8888407 17688650 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Zinc |
6.64 | 19302082 |
MESH:D007562 |
Creutzfeldt-Jakob Syndrome |
marker/mechanism |
|
| |
MESH:D007644 |
Darier Disease |
|
Fluorouracil |
4.31 | 16733453 |
MESH:D003643 |
Death |
|
Toluene |
5.18 | 6431079 |
MESH:D003872 |
Dermatitis |
|
Benzene |
4.30 | 15902427 |
MESH:D017449 |
Dermatitis, Allergic Contact |
|
4,4'-diaminodiphenylmethane |
5.74 | 8156756 11298694 12868966 8970840 11906362 14531868 2524372 18759878 |
MESH:D017449 |
Dermatitis, Allergic Contact |
|
Nickel |
5.74 | 17244072 19470301 17100760 |
MESH:D003876 |
Dermatitis, Atopic |
|
pirinixic acid |
2.19 | 18249437 |
MESH:D003877 |
Dermatitis, Contact |
|
4,4'-diaminodiphenylmethane |
8.08 | 2952479 3621924 |
MESH:D003877 |
Dermatitis, Contact |
|
Nickel |
8.08 | 2952479 |
MESH:D003920 |
Diabetes Mellitus |
|
Zinc |
3.80 | 16479319 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Diethylnitrosamine |
6.28 | 20387270 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Genistein |
6.28 | 16647724 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Tetrachlorodibenzodioxin |
6.28 | 17107852 |
MESH:D003929 |
Diabetic Neuropathies |
|
Progesterone |
4.03 | 17187935 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
4,4'-diaminodiphenylmethane |
16.12 | 8291058 1440618 18648102 9328219 18289764 18692083 11289319 9022650 7440962 6482804 16192314 9653073 6679447 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Diethylnitrosamine |
16.12 | 19107877 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Doxorubicin |
16.12 | 17416283 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Tetrachlorodibenzodioxin |
16.12 | 20420201 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Tetracycline |
16.12 | 17522070 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Trichloroethylene |
16.12 | 7120509 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Valproic Acid |
16.12 | 19641884 1733752 |
MESH:D004362 |
Drug Toxicity |
|
Cisplatin |
11.71 | 19839026 12649298 12231392 15033597 |
MESH:D004362 |
Drug Toxicity |
|
Doxorubicin |
11.71 | 18602426 |
MESH:D004362 |
Drug Toxicity |
|
Tetrachlorodibenzodioxin |
11.71 | 11462148 |
MESH:D004421 |
Dystonia |
|
Valproic Acid |
3.61 | 1851702 |
MESH:D004487 |
Edema |
|
pirinixic acid |
5.16 | 12083418 |
MESH:D004487 |
Edema |
|
Tetrachlorodibenzodioxin |
5.16 | 11000095 12711302 |
MESH:D004489 |
Edema, Cardiac |
|
Tetrachlorodibenzodioxin |
3.42 | 15322242 16714409 18230668 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
Calcitriol |
12.76 | 15138306 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
Ethinyl Estradiol |
12.76 | 12538720 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
Progesterone |
12.76 | 17692515 |
MESH:D004714 |
Endometrial Hyperplasia |
|
Genistein |
4.11 | 16402032 |
MESH:D016889 |
Endometrial Neoplasms |
|
Doxorubicin |
6.61 | 17359293 |
MESH:D016889 |
Endometrial Neoplasms |
|
Genistein |
6.61 | 11473722 |
MESH:D004715 |
Endometriosis |
|
Progesterone |
7.56 | 16134523 |
MESH:D004715 |
Endometriosis |
|
Tetrachlorodibenzodioxin |
7.56 | 10568697 9294722 |
MESH:D004719 |
Endomyocardial Fibrosis |
|
Doxorubicin |
4.67 | 18037988 |
MESH:D019446 |
Endotoxemia |
|
Lipopolysaccharides |
3.92 | 15328337 15821434 17637181 |
MESH:D004831 |
Epilepsies, Myoclonic |
|
Valproic Acid |
3.69 | 3659116 17275665 |
MESH:D004828 |
Epilepsies, Partial |
|
Valproic Acid |
3.43 | 16628512 3922381 |
MESH:D004827 |
Epilepsy |
|
Valproic Acid |
2.68 | 18234410 20417680 |
MESH:D004832 |
Epilepsy, Absence |
|
Valproic Acid |
3.19 | 7562514 6254150 6426943 |
MESH:D017029 |
Epilepsy, Complex Partial |
|
Valproic Acid |
3.83 | 7750514 |
MESH:D004830 |
Epilepsy, Tonic-Clonic |
|
Valproic Acid |
3.59 | 3659116 |
MESH:D004931 |
Esophageal Achalasia |
|
Diethylnitrosamine |
4.63 | 16302075 |
MESH:D004938 |
Esophageal Neoplasms |
|
4,4'-diaminodiphenylmethane |
12.28 | 3581430 |
MESH:D004938 |
Esophageal Neoplasms |
|
Cisplatin |
12.28 | 15173087 16785472 16481741 17638652 15464296 |
MESH:D004938 |
Esophageal Neoplasms |
|
Fluorouracil |
12.28 | 16337965 16481741 16785472 17638652 15173087 |
MESH:D004938 |
Esophageal Neoplasms |
|
nitrosobenzylmethylamine |
12.28 | 15547721 15150132 15264214 16704527 15547733 15878914 16510608 16805852 15623463 |
MESH:D004938 |
Esophageal Neoplasms |
|
Zinc |
12.28 | 16543248 |
MESH:D005124 |
Eye Abnormalities |
|
Tetrachlorodibenzodioxin |
2.65 | 11564622 |
MESH:D005234 |
Fatty Liver |
|
Cyclosporine |
25.21 | 19224547 |
MESH:D005234 |
Fatty Liver |
|
Diethylnitrosamine |
25.21 | 21071580 20387270 |
MESH:D005234 |
Fatty Liver |
|
Ethinyl Estradiol |
25.21 | 15345470 |
MESH:D005234 |
Fatty Liver |
|
pirinixic acid |
25.21 | 19236843 20131406 |
MESH:D005234 |
Fatty Liver |
|
Tetracycline |
25.21 | 19224547 16917069 |
MESH:D005234 |
Fatty Liver |
|
Valproic Acid |
25.21 | 19224547 14986274 |
MESH:D005313 |
Fetal Death |
|
Tetrachlorodibenzodioxin |
2.99 | 11858732 |
MESH:D005315 |
Fetal Diseases |
|
Valproic Acid |
4.40 | 16575769 |
MESH:D005317 |
Fetal Growth Retardation |
|
Valproic Acid |
3.68 | 18558336 8888407 |
MESH:D005334 |
Fever |
|
Lipopolysaccharides |
3.60 | 11852909 9205823 |
MESH:D005350 |
Fibroma |
|
4,4'-diaminodiphenylmethane |
4.53 | 6705139 |
MESH:D018222 |
Fibromatosis, Aggressive |
|
Doxorubicin |
4.11 | 19069698 |
MESH:D005355 |
Fibrosis |
|
Cyclosporine |
6.95 | 12639820 12168785 |
MESH:D005355 |
Fibrosis |
|
Tetrachlorodibenzodioxin |
6.95 | 20067830 |
MESH:D005756 |
Gastritis |
|
Zinc |
4.31 | 17241300 |
MESH:D005833 |
Genital Neoplasms, Female |
|
sodium arsenite |
4.20 | 16452187 |
MESH:D016098 |
Gerstmann-Straussler-Scheinker Disease |
marker/mechanism |
|
| 10203975 |
MESH:D005885 |
Gingival Hyperplasia |
|
Cyclosporine |
3.74 | 8708960 |
MESH:D005909 |
Glioblastoma |
|
Doxorubicin |
6.27 | 17150277 |
MESH:D005909 |
Glioblastoma |
|
Genistein |
6.27 | 16598420 |
MESH:D005910 |
Glioma |
|
Fluorouracil |
2.67 | 16145905 |
MESH:D005911 |
Gliosis |
|
Paraquat |
4.68 | 11124998 |
MESH:D006042 |
Goiter |
|
4,4'-diaminodiphenylmethane |
3.60 | 7505956 |
MESH:D006058 |
Gonadal Disorders |
|
Tetrachlorodibenzodioxin |
4.11 | 10696789 |
MESH:D006130 |
Growth Disorders |
|
Zinc |
3.65 | 17217573 |
MESH:D006258 |
Head and Neck Neoplasms |
|
Cisplatin |
11.14 | 15464296 15102660 |
MESH:D006258 |
Head and Neck Neoplasms |
|
Doxorubicin |
11.14 | 15692506 |
MESH:D006258 |
Head and Neck Neoplasms |
|
Fluorouracil |
11.14 | 18337622 15102660 15162350 |
MESH:D034381 |
Hearing Loss |
|
Cisplatin |
3.90 | 19898482 |
MESH:D006319 |
Hearing Loss, Sensorineural |
|
Cisplatin |
4.03 | 15464296 |
MESH:D006330 |
Heart Defects, Congenital |
|
Tetrachlorodibenzodioxin |
2.07 | 10048152 11294989 |
MESH:D006331 |
Heart Diseases |
|
Doxorubicin |
3.15 | 16330681 16144979 16707910 16244371 16495754 16879835 18674790 14766674 16244372 17875725 17888722 12587719 18006777 |
MESH:D006333 |
Heart Failure |
|
Doxorubicin |
10.11 | 17481944 |
MESH:D006333 |
Heart Failure |
|
pirinixic acid |
10.11 | 20558911 |
MESH:D006333 |
Heart Failure |
|
Zinc |
10.11 | 17162251 |
MESH:D006335 |
Heart Injuries |
|
Zinc |
5.28 | 17074742 |
MESH:D016481 |
Helicobacter Infections |
|
Zinc |
4.09 | 17241300 |
MESH:D006394 |
Hemangiosarcoma |
|
Doxorubicin |
3.48 | 15692506 |
MESH:D006402 |
Hematologic Diseases |
|
Benzene |
4.21 | 16183116 |
MESH:D006457 |
Hemoglobinuria, Paroxysmal |
|
Cyclosporine |
3.94 | 15720958 |
MESH:D006463 |
Hemolytic-Uremic Syndrome |
|
Lipopolysaccharides |
3.97 | 16366002 |
MESH:D006470 |
Hemorrhage |
|
Tetrachlorodibenzodioxin |
2.91 | 11000095 |
MESH:D006505 |
Hepatitis |
|
4,4'-diaminodiphenylmethane |
3.06 | 6705139 |
MESH:D006521 |
Hepatitis, Chronic |
|
Copper |
4.79 | 17338147 |
MESH:D006527 |
Hepatolenticular Degeneration |
marker/mechanism |
|
| 16831968 |
MESH:D006527 |
Hepatolenticular Degeneration |
|
Copper |
9.83 | 17109627 17182432 17276780 19888908 16607473 |
MESH:D006527 |
Hepatolenticular Degeneration |
|
Zinc |
9.83 | 17276780 |
MESH:D006529 |
Hepatomegaly |
|
2-xylene |
11.91 | 7457028 7457013 |
MESH:D006529 |
Hepatomegaly |
|
pirinixic acid |
11.91 | 16221962 18467677 19176532 19772884 |
MESH:D006529 |
Hepatomegaly |
|
Tetrachlorodibenzodioxin |
11.91 | 15340226 16120746 12621046 |
MESH:D006561 |
Herpes Simplex |
|
Etoposide |
4.09 | 10809021 |
MESH:D015658 |
HIV Infections |
|
Nickel |
3.56 | 17263646 |
MESH:D006689 |
Hodgkin Disease |
|
Cisplatin |
18.74 | 16200630 16170182 |
MESH:D006689 |
Hodgkin Disease |
|
Doxorubicin |
18.74 | 18501091 15147373 17606976 |
MESH:D006689 |
Hodgkin Disease |
|
Etoposide |
18.74 | 17606976 16135485 16200630 15147373 18180244 |
MESH:D006689 |
Hodgkin Disease |
|
sodium arsenite |
18.74 | 12676792 |
MESH:D006689 |
Hodgkin Disease |
|
Vincristine |
18.74 | 15147373 16794504 17606976 16135485 |
OMIM:603218 |
HUNTINGTON DISEASE-LIKE 1 |
marker/mechanism |
|
| |
MESH:D006849 |
Hydrocephalus |
|
Valproic Acid |
4.39 | 17688650 |
MESH:D006869 |
Hydronephrosis |
|
Tetrachlorodibenzodioxin |
3.56 | 15340226 16959395 16354765 8697196 18606429 |
MESH:D006943 |
Hyperglycemia |
|
pirinixic acid |
2.77 | 20558911 |
MESH:D006965 |
Hyperplasia |
|
4,4'-diaminodiphenylmethane |
3.47 | 15034207 |
MESH:D006973 |
Hypertension |
|
Benzene |
7.43 | 17940673 |
MESH:D006973 |
Hypertension |
|
Cyclosporine |
7.43 | 10903974 |
MESH:D006973 |
Hypertension |
|
Tetrachlorodibenzodioxin |
7.43 | 18670907 18850075 |
MESH:D006976 |
Hypertension, Pulmonary |
|
Copper Sulfate |
4.73 | 7265320 |
MESH:D007021 |
Hypospadias |
|
Ethinyl Estradiol |
3.34 | 16569931 16945680 |
MESH:D020244 |
Infarction, Middle Cerebral Artery |
|
Progesterone |
3.94 | 15869954 |
MESH:D007247 |
Infertility, Female |
|
Ethinyl Estradiol |
3.02 | 12013081 |
MESH:D007248 |
Infertility, Male |
|
Ethinyl Estradiol |
9.35 | 17937319 |
MESH:D007248 |
Infertility, Male |
|
Paraquat |
9.35 | 4850670 |
MESH:D007248 |
Infertility, Male |
|
sodium arsenite |
9.35 | 12646999 15346721 |
MESH:D007249 |
Inflammation |
|
Diethylnitrosamine |
13.07 | 18785209 |
MESH:D007249 |
Inflammation |
|
Lipopolysaccharides |
13.07 | 12878042 9205823 17237260 17963957 17255318 |
MESH:D007249 |
Inflammation |
|
Nickel |
13.07 | 16166738 |
MESH:D007249 |
Inflammation |
|
Progesterone |
13.07 | 15869954 |
MESH:D007249 |
Inflammation |
|
Tetrachlorodibenzodioxin |
13.07 | 12200463 12878042 |
MESH:D034062 |
Insomnia, Fatal Familial |
marker/mechanism |
|
| |
MESH:D007333 |
Insulin Resistance |
|
bisphenol A |
6.25 | 16393666 |
MESH:D007333 |
Insulin Resistance |
|
pirinixic acid |
6.25 | 16306350 |
MESH:D019189 |
Iron Metabolism Disorders |
|
Lipopolysaccharides |
4.19 | 17255318 |
MESH:D007511 |
Ischemia |
|
Zinc |
4.17 | 16584753 |
MESH:D007565 |
Jaundice |
|
4,4'-diaminodiphenylmethane |
4.53 | 9022650 8074119 |
MESH:D007569 |
Jaw Abnormalities |
|
Tetrachlorodibenzodioxin |
2.91 | 16580747 |
MESH:D007638 |
Keratoconjunctivitis Sicca |
|
Cyclosporine |
3.95 | 15604871 |
MESH:D007673 |
Kidney Cortex Necrosis |
|
Cisplatin |
4.65 | 15464296 |
MESH:D007674 |
Kidney Diseases |
|
Cadmium Chloride |
20.14 | 16962696 |
MESH:D007674 |
Kidney Diseases |
|
Cisplatin |
20.14 | 12649298 12231392 19839026 18289764 15190930 |
MESH:D007674 |
Kidney Diseases |
|
Cyclosporine |
20.14 | 8314463 10903974 18776723 |
MESH:D007674 |
Kidney Diseases |
|
Doxorubicin |
20.14 | 15699352 16775033 15369732 |
MESH:D007674 |
Kidney Diseases |
|
sodium arsenite |
20.14 | 20008137 |
MESH:D007674 |
Kidney Diseases |
|
Zinc |
20.14 | 16960431 |
MESH:D007676 |
Kidney Failure, Chronic |
|
Copper |
20.39 | 16518626 |
MESH:D007676 |
Kidney Failure, Chronic |
|
Doxorubicin |
20.39 | 16707910 |
MESH:D007676 |
Kidney Failure, Chronic |
|
Hydrogen Peroxide |
20.39 | 16518626 |
MESH:D007676 |
Kidney Failure, Chronic |
|
Zinc |
20.39 | 16518626 |
MESH:D007680 |
Kidney Neoplasms |
|
4,4'-diaminodiphenylmethane |
10.17 | 6582329 |
MESH:D007680 |
Kidney Neoplasms |
|
Cyclosporine |
10.17 | 12371664 |
MESH:D007680 |
Kidney Neoplasms |
|
Fluorouracil |
10.17 | 16985049 |
MESH:D007683 |
Kidney Tubular Necrosis, Acute |
|
Cisplatin |
4.31 | 11231351 |
MESH:D007859 |
Learning Disorders |
|
Copper |
4.33 | 17134702 |
MESH:D007938 |
Leukemia |
|
Benzene |
5.79 | 18335105 15935818 14694614 17119257 |
MESH:D007938 |
Leukemia |
|
Genistein |
5.79 | 17468513 18980019 |
MESH:D004915 |
Leukemia, Erythroblastic, Acute |
|
Doxorubicin |
4.67 | 16085563 |
MESH:D007951 |
Leukemia, Myeloid |
|
Benzene |
3.89 | 17506065 |
MESH:D015470 |
Leukemia, Myeloid, Acute |
|
Benzene |
3.76 | 19478238 |
MESH:D015470 |
Leukemia, Myeloid, Acute |
|
Valproic Acid |
3.76 | 16294345 17596541 |
MESH:D007970 |
Leukopenia |
|
Lipopolysaccharides |
4.22 | 15821434 |
MESH:D008103 |
Liver Cirrhosis |
|
Diethylnitrosamine |
2.55 | 18407596 18522880 20032147 19638242 18665156 |
MESH:D008105 |
Liver Cirrhosis, Biliary |
|
4,4'-diaminodiphenylmethane |
2.89 | 9327722 15034207 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Doxorubicin |
5.95 | 16439617 16595196 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Genistein |
5.95 | 17823541 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Lipopolysaccharides |
5.95 | 12878042 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
pirinixic acid |
5.95 | 15474484 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tetrachlorodibenzodioxin |
5.95 | 12878042 |
MESH:D008107 |
Liver Diseases |
|
Diethylnitrosamine |
1.98 | 17034775 |
MESH:D008113 |
Liver Neoplasms |
|
Copper |
18.78 | 20302851 |
MESH:D008113 |
Liver Neoplasms |
|
Diethylnitrosamine |
18.78 | 19427195 12112319 20492335 21167192 2862719 19690152 21071580 19426721 19073162 19294768 19642983 20137499 2422723 19638242 18644402 12771043 9163691 20583210 19551842 19255062 20118626 19499222 20405173 19254457 20452335 18648771 18978307 19996281 20434301 15175105 20501860 18977376 18754104 15885732 19850985 20101389 19256749 21278145 19833225 16942905 21047994 10737359 19090486 19812893 |
MESH:D008113 |
Liver Neoplasms |
|
Fluorouracil |
18.78 | 17045692 18383874 15113037 16603448 |
MESH:D008113 |
Liver Neoplasms |
|
Mitomycin |
18.78 | 15113037 |
MESH:D008113 |
Liver Neoplasms |
|
pirinixic acid |
18.78 | 15890375 20007298 16377806 |
MESH:D008113 |
Liver Neoplasms |
|
sodium arsenite |
18.78 | 16712894 15276417 |
MESH:D008113 |
Liver Neoplasms |
|
Tetrachlorodibenzodioxin |
18.78 | 16984957 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
4,4'-diaminodiphenylmethane |
19.38 | 6587162 1399818 598648 3712494 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Benzene |
19.38 | 12562636 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Diethylnitrosamine |
19.38 | 19009564 18253720 21159647 18775883 18282651 18164116 18308698 17942915 16267830 18093689 19539802 18544905 16842330 17854601 18079962 17174075 9362446 19126423 19004024 19519916 2563599 3124819 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Doxorubicin |
19.38 | 16842330 17085340 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Tetrachlorodibenzodioxin |
19.38 | 12151625 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Trichloroethylene |
19.38 | 7955063 |
MESH:D008171 |
Lung Diseases |
|
sodium arsenite |
2.85 | 19095001 |
MESH:D017563 |
Lung Diseases, Interstitial |
|
Benzene |
9.77 | 14698565 |
MESH:D017563 |
Lung Diseases, Interstitial |
|
Valproic Acid |
9.77 | 17228818 |
MESH:D055370 |
Lung Injury |
|
Lipopolysaccharides |
3.55 | 21114838 |
MESH:D008175 |
Lung Neoplasms |
|
Benzene |
16.27 | 12562636 |
MESH:D008175 |
Lung Neoplasms |
|
bexarotene |
16.27 | 17849452 |
MESH:D008175 |
Lung Neoplasms |
|
Cisplatin |
16.27 | 11798837 17225452 6189445 |
MESH:D008175 |
Lung Neoplasms |
|
Diethylnitrosamine |
16.27 | 21163286 20970405 6695378 20512841 |
MESH:D008175 |
Lung Neoplasms |
|
Doxorubicin |
16.27 | 17418594 6189445 |
MESH:D008175 |
Lung Neoplasms |
|
Fluorouracil |
16.27 | 15246190 |
MESH:D008175 |
Lung Neoplasms |
|
Methylene Chloride |
16.27 | 15172992 |
MESH:D008175 |
Lung Neoplasms |
|
sodium arsenite |
16.27 | 19931552 17077188 16712894 17306315 15276417 |
MESH:D008175 |
Lung Neoplasms |
|
Tetrachlorodibenzodioxin |
16.27 | 19555203 11884234 |
MESH:D008175 |
Lung Neoplasms |
|
Vincristine |
16.27 | 19825857 6189445 |
MESH:D008178 |
Lupus Erythematosus, Cutaneous |
|
Fluorouracil |
4.31 | 15086387 |
MESH:D008223 |
Lymphoma |
|
Benzene |
10.74 | 17584886 17119257 |
MESH:D008223 |
Lymphoma |
|
Doxorubicin |
10.74 | 16098063 |
MESH:D008223 |
Lymphoma |
|
Etoposide |
10.74 | 12854902 12556972 |
MESH:D008228 |
Lymphoma, Non-Hodgkin |
|
Doxorubicin |
3.40 | 17654614 |
MESH:D016399 |
Lymphoma, T-Cell |
|
Doxorubicin |
4.10 | 15621674 |
MESH:D016410 |
Lymphoma, T-Cell, Cutaneous |
|
bexarotene |
4.68 | 11161223 |
MESH:D015674 |
Mammary Neoplasms, Animal |
|
Benzene |
3.97 | 12562636 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Benzene |
19.49 | 11921183 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
bexarotene |
19.49 | 19196723 15591091 19196722 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Doxorubicin |
19.49 | 15458769 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Genistein |
19.49 | 14578162 12929590 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Progesterone |
19.49 | 17203775 11408345 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Zinc |
19.49 | 12773700 |
MESH:D008545 |
Melanoma |
|
Cisplatin |
4.62 | 18332650 12374674 17761969 16809738 18505091 18176117 16248763 15577323 11135225 12393984 16432458 17023156 12883367 |
MESH:D008545 |
Melanoma |
|
Doxorubicin |
4.62 | 16827129 |
MESH:D008545 |
Melanoma |
|
sodium arsenite |
4.62 | 19082730 16487513 |
MESH:D018328 |
Melanoma, Amelanotic |
|
Cisplatin |
10.51 | 15990972 |
MESH:D018328 |
Melanoma, Amelanotic |
|
Vincristine |
10.51 | 15990972 |
MESH:D007706 |
Menkes Kinky Hair Syndrome |
|
Copper |
5.40 | 17109627 17268249 |
MESH:D008607 |
Mental Retardation |
|
Toluene |
3.47 | 9294310 |
MESH:D008654 |
Mesothelioma |
|
Cisplatin |
5.76 | 17638057 |
MESH:D008654 |
Mesothelioma |
|
Doxorubicin |
5.76 | 17638057 |
MESH:D008664 |
Metal Metabolism, Inborn Errors |
|
Cyclosporine |
4.30 | 16801185 |
MESH:D008881 |
Migraine Disorders |
|
Valproic Acid |
2.85 | 18765137 18803445 |
MESH:D028361 |
Mitochondrial Diseases |
|
Doxorubicin |
4.07 | 15792986 |
MESH:D019957 |
Motor Skills Disorders |
|
Toluene |
4.79 | 9294310 |
MESH:D009062 |
Mouth Neoplasms |
|
Fluorouracil |
3.27 | 16757204 18986760 |
MESH:D052016 |
Mucositis |
|
Doxorubicin |
4.31 | 17415656 |
MESH:D009101 |
Multiple Myeloma |
|
Benzene |
3.32 | 17119195 |
MESH:D009135 |
Muscular Diseases |
|
pirinixic acid |
3.04 | 16239165 |
MESH:D009139 |
Musculoskeletal Abnormalities |
|
Valproic Acid |
3.60 | 8888407 |
MESH:D009190 |
Myelodysplastic Syndromes |
|
Valproic Acid |
2.87 | 17596541 |
MESH:D009203 |
Myocardial Infarction |
|
Doxorubicin |
11.82 | 15857846 19429709 |
MESH:D009203 |
Myocardial Infarction |
|
Genistein |
11.82 | 17141266 |
MESH:D009203 |
Myocardial Infarction |
|
pirinixic acid |
11.82 | 19151258 |
MESH:D009203 |
Myocardial Infarction |
|
Vincristine |
11.82 | 17284715 |
MESH:D017202 |
Myocardial Ischemia |
|
Tetrachlorodibenzodioxin |
2.64 | 12213967 |
MESH:D015428 |
Myocardial Reperfusion Injury |
|
Genistein |
7.17 | 17141266 |
MESH:D015428 |
Myocardial Reperfusion Injury |
|
pirinixic acid |
7.17 | 16411023 |
MESH:D009362 |
Neoplasm Metastasis |
|
4,4'-diaminodiphenylmethane |
8.28 | 3581430 |
MESH:D009362 |
Neoplasm Metastasis |
|
Diethylnitrosamine |
8.28 | 3581430 9029167 |
MESH:D009362 |
Neoplasm Metastasis |
|
Doxorubicin |
8.28 | 18259882 |
MESH:D009369 |
Neoplasms |
|
Cisplatin |
13.06 | 16773208 |
MESH:D009369 |
Neoplasms |
|
Fluorouracil |
13.06 | 18239605 16928823 18600527 |
MESH:D009369 |
Neoplasms |
|
pirinixic acid |
13.06 | 17405874 |
MESH:D009369 |
Neoplasms |
|
sodium arsenite |
13.06 | 11559025 |
MESH:D009369 |
Neoplasms |
|
Trichloroethylene |
13.06 | 11911487 |
MESH:D009374 |
Neoplasms, Experimental |
|
sodium arsenite |
3.21 | 20056578 |
MESH:D009376 |
Neoplasms, Hormone-Dependent |
|
bexarotene |
4.30 | 19196722 |
MESH:D009389 |
Neovascularization, Pathologic |
|
Copper |
4.47 | 17308104 |
MESH:D009395 |
Nephritis, Interstitial |
|
Cisplatin |
9.23 | 15464296 |
MESH:D009395 |
Nephritis, Interstitial |
|
Tetracycline |
9.23 | 9884423 |
MESH:D009401 |
Nephrosis |
|
Doxorubicin |
4.30 | 16899518 16636307 |
MESH:D009402 |
Nephrosis, Lipoid |
|
Cyclosporine |
3.95 | 17954296 |
MESH:D009404 |
Nephrotic Syndrome |
|
Cyclosporine |
7.96 | 19348381 18481113 |
MESH:D009404 |
Nephrotic Syndrome |
|
Doxorubicin |
7.96 | 15640375 16889571 |
MESH:D009410 |
Nerve Degeneration |
|
Paraquat |
3.35 | 16893418 |
MESH:D009421 |
Nervous System Malformations |
|
bisphenol A |
13.79 | 11399458 16427766 |
MESH:D009421 |
Nervous System Malformations |
|
Genistein |
13.79 | 16427766 |
MESH:D009421 |
Nervous System Malformations |
|
Tetrachlorodibenzodioxin |
13.79 | 14600291 |
MESH:D009436 |
Neural Tube Defects |
|
4,4'-diaminodiphenylmethane |
14.73 | 6679447 |
MESH:D009436 |
Neural Tube Defects |
|
Benzene |
14.73 | 15643154 |
MESH:D009436 |
Neural Tube Defects |
|
sodium arsenite |
14.73 | 12854658 |
MESH:D009436 |
Neural Tube Defects |
|
Valproic Acid |
14.73 | 8888407 16359493 |
MESH:D009447 |
Neuroblastoma |
|
Cisplatin |
6.27 | 8761367 |
MESH:D009447 |
Neuroblastoma |
|
Doxorubicin |
6.27 | 15555623 |
MESH:D019636 |
Neurodegenerative Diseases |
|
Diethylnitrosamine |
2.96 | 20387270 |
MESH:D017599 |
Neuroectodermal Tumors |
|
Cisplatin |
10.24 | 8761367 |
MESH:D017599 |
Neuroectodermal Tumors |
|
Vincristine |
10.24 | 12837982 |
MESH:D009461 |
Neurologic Manifestations |
|
Diethylnitrosamine |
4.63 | 20387270 |
MESH:D020258 |
Neurotoxicity Syndromes |
|
Fluorouracil |
3.11 | 16436463 |
MESH:D009765 |
Obesity |
|
pirinixic acid |
1.69 | 20558911 |
MESH:D009784 |
Occupational Diseases |
|
4,4'-diaminodiphenylmethane |
7.79 | 6482804 4026338 |
MESH:D009784 |
Occupational Diseases |
|
Benzene |
7.79 | 15913788 17479406 15612468 15935809 16737584 15576619 17119257 17178637 15727169 |
MESH:D009902 |
Optic Neuritis |
|
4,4'-diaminodiphenylmethane |
4.53 | 3988306 |
MESH:D010024 |
Osteoporosis |
|
Genistein |
2.95 | 19401787 |
MESH:D015663 |
Osteoporosis, Postmenopausal |
|
Genistein |
3.65 | 16169203 |
MESH:D012516 |
Osteosarcoma |
|
Doxorubicin |
3.73 | 15930896 |
MESH:D010049 |
Ovarian Diseases |
|
bisphenol A |
4.51 | 11985600 |
MESH:D010051 |
Ovarian Neoplasms |
|
Benzene |
13.15 | 12562636 |
MESH:D010051 |
Ovarian Neoplasms |
|
Cisplatin |
13.15 | 19769630 6897625 15464296 17225452 |
MESH:D010051 |
Ovarian Neoplasms |
|
Genistein |
13.15 | 19005980 |
MESH:D010051 |
Ovarian Neoplasms |
|
Progesterone |
13.15 | 16525653 17393432 |
MESH:D010051 |
Ovarian Neoplasms |
|
sodium arsenite |
13.15 | 17306315 15276417 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Cisplatin |
14.29 | 19003803 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Diethylnitrosamine |
14.29 | 16540662 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Etoposide |
14.29 | 19003803 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Fluorouracil |
14.29 | 19003803 16929163 15113037 16500647 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Mitomycin |
14.29 | 15113037 |
MESH:D016584 |
Panic Disorder |
|
Ethinyl Estradiol |
3.25 | 11578682 |
MESH:D010212 |
Papilloma |
|
4,4'-diaminodiphenylmethane |
7.78 | 7296757 |
MESH:D010212 |
Papilloma |
|
Hydrogen Peroxide |
7.78 | 12065085 |
MESH:D010300 |
Parkinson Disease |
|
Paraquat |
2.63 | 15451049 15824117 12911755 11445065 16510128 11124998 11181820 16140633 |
MESH:D010302 |
Parkinson Disease, Secondary |
|
Paraquat |
3.97 | 16190885 |
MESH:D010382 |
Peliosis Hepatis |
|
Tetrachlorodibenzodioxin |
3.76 | 12520081 |
MESH:D010391 |
Pemphigoid, Bullous |
|
Tetracycline |
4.95 | 11026799 |
MESH:D010523 |
Peripheral Nervous System Diseases |
|
Cisplatin |
3.86 | 15464296 |
MESH:D010787 |
Photosensitivity Disorders |
|
4,4'-diaminodiphenylmethane |
3.98 | 6228378 |
MESH:D003557 |
Phyllodes Tumor |
|
Doxorubicin |
4.67 | 17983394 |
MESH:D010997 |
Pleural Neoplasms |
|
Cisplatin |
12.32 | 17638057 |
MESH:D010997 |
Pleural Neoplasms |
|
Doxorubicin |
12.32 | 17638057 |
MESH:D011014 |
Pneumonia |
|
Lipopolysaccharides |
9.54 | 11605937 12224865 |
MESH:D011014 |
Pneumonia |
|
Paraquat |
9.54 | 12504350 |
MESH:D017119 |
Porphyria Cutanea Tarda |
|
Tetrachlorodibenzodioxin |
3.11 | 18163543 |
MESH:D011230 |
Precancerous Conditions |
|
Cyclosporine |
7.61 | 12371664 |
MESH:D011230 |
Precancerous Conditions |
|
Diethylnitrosamine |
7.61 | 2563599 |
MESH:D054198 |
Precursor Cell Lymphoblastic Leukemia-Lymphoma |
|
Vincristine |
4.34 | 21297632 |
MESH:D011225 |
Pre-Eclampsia |
|
Zinc |
3.81 | 17114810 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
bisphenol A |
13.49 | 10548101 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
Tetrachlorodibenzodioxin |
13.49 | 11118676 11222880 11896295 11399792 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
Valproic Acid |
13.49 | 20603192 |
MESH:D017096 |
Prion Diseases |
marker/mechanism |
|
| 17257012 17274528 |
MESH:D017096 |
Prion Diseases |
|
Tetracycline |
4.94 | 10903871 |
MESH:D011470 |
Prostatic Hyperplasia |
|
Calcitriol |
4.30 | 15572423 |
MESH:D019048 |
Prostatic Intraepithelial Neoplasia |
|
bisphenol A |
3.78 | 20887781 |
MESH:D011471 |
Prostatic Neoplasms |
marker/mechanism |
|
| 17199135 |
MESH:D011471 |
Prostatic Neoplasms |
|
AGN 194204 |
3.92 | 16000583 |
MESH:D011471 |
Prostatic Neoplasms |
|
bisphenol A |
3.92 | 16740699 |
MESH:D011471 |
Prostatic Neoplasms |
|
Calcitriol |
3.92 | 16644109 16289102 15754350 18247401 12479363 |
MESH:D011471 |
Prostatic Neoplasms |
|
Copper |
3.92 | 17308104 17079463 |
MESH:D011471 |
Prostatic Neoplasms |
|
Doxorubicin |
3.92 | 15749863 15897917 16888761 16729912 16868541 18437689 |
MESH:D011471 |
Prostatic Neoplasms |
|
Etoposide |
3.92 | 17172428 |
MESH:D011471 |
Prostatic Neoplasms |
|
Fluorouracil |
3.92 | 19082440 18626508 |
MESH:D011471 |
Prostatic Neoplasms |
|
Genistein |
3.92 | 15378649 16925846 15256057 |
MESH:D011471 |
Prostatic Neoplasms |
|
methylselenic acid |
3.92 | 16205645 |
MESH:D011471 |
Prostatic Neoplasms |
|
sodium arsenite |
3.92 | 16039940 |
MESH:D011471 |
Prostatic Neoplasms |
|
Zinc |
3.92 | 12429649 16606632 16517595 16700911 |
MESH:D011537 |
Pruritus |
|
Ethinyl Estradiol |
2.84 | 16919318 15861022 |
MESH:D019310 |
Pseudolymphoma |
|
Valproic Acid |
4.06 | 12752131 11422049 |
MESH:D011565 |
Psoriasis |
|
Cyclosporine |
2.05 | 16882103 |
MESH:D011629 |
Puberty, Precocious |
|
bisphenol A |
4.31 | 10548101 |
MESH:D011658 |
Pulmonary Fibrosis |
|
Paraquat |
2.72 | 16324872 17997886 |
MESH:D012004 |
Rectal Neoplasms |
|
Fluorouracil |
3.61 | 16160472 18722050 15538739 18286688 |
MESH:D051437 |
Renal Insufficiency |
|
Cisplatin |
8.83 | 15464296 |
MESH:D051437 |
Renal Insufficiency |
|
Doxorubicin |
8.83 | 17922066 |
MESH:D015427 |
Reperfusion Injury |
|
pirinixic acid |
2.14 | 19058328 |
MESH:D012128 |
Respiratory Distress Syndrome, Adult |
|
Paraquat |
3.47 | 11700416 |
MESH:D012130 |
Respiratory Hypersensitivity |
|
Lipopolysaccharides |
3.41 | 10835634 |
MESH:D012135 |
Respiratory Sounds |
|
Paraquat |
3.59 | 11874814 |
MESH:D015619 |
Respiratory System Abnormalities |
|
Tetrachlorodibenzodioxin |
3.38 | 18990726 |
MESH:D012162 |
Retinal Degeneration |
|
4,4'-diaminodiphenylmethane |
12.90 | 3692021 |
MESH:D012162 |
Retinal Degeneration |
|
Paraquat |
12.90 | 16458197 |
MESH:D012162 |
Retinal Degeneration |
|
Zinc |
12.90 | 16584753 |
MESH:D012208 |
Rhabdomyosarcoma |
|
Valproic Acid |
3.73 | 19155313 |
MESH:D012468 |
Salivary Gland Neoplasms |
|
Progesterone |
2.67 | 18045962 |
MESH:D012509 |
Sarcoma |
|
Doxorubicin |
3.58 | 17203757 16767912 17710206 15625365 18313854 15675481 |
MESH:D012512 |
Sarcoma, Ewing's |
|
Cisplatin |
14.77 | 14601052 |
MESH:D012512 |
Sarcoma, Ewing's |
|
Doxorubicin |
14.77 | 16326096 14601052 |
MESH:D012512 |
Sarcoma, Ewing's |
|
Etoposide |
14.77 | 14601052 |
MESH:D012514 |
Sarcoma, Kaposi |
|
Doxorubicin |
4.31 | 17846226 |
MESH:D012559 |
Schizophrenia |
|
Copper |
3.66 | 16842975 |
MESH:D012559 |
Schizophrenia |
|
Valproic Acid |
3.66 | 15737665 19110320 |
MESH:D012640 |
Seizures |
|
Toluene |
5.29 | 9294310 6431079 |
MESH:D012640 |
Seizures |
|
Valproic Acid |
5.29 | 14763951 3137016 16876388 11044598 17978042 1511512 15475178 11738929 |
MESH:D012878 |
Skin Neoplasms |
|
Doxorubicin |
15.35 | 15692506 |
MESH:D012878 |
Skin Neoplasms |
|
Hydrogen Peroxide |
15.35 | 12065085 |
MESH:D012878 |
Skin Neoplasms |
|
sodium arsenite |
15.35 | 18572023 19524636 |
MESH:D012878 |
Skin Neoplasms |
|
tert-Butylhydroperoxide |
15.35 | 8532709 |
MESH:D012878 |
Skin Neoplasms |
|
Tetrachlorodibenzodioxin |
15.35 | 16192470 |
MESH:D055752 |
Small Cell Lung Carcinoma |
|
Cisplatin |
4.86 | 15464296 |
MESH:D012983 |
Soft Tissue Neoplasms |
|
Doxorubicin |
4.10 | 17203757 16767912 15625365 |
MESH:D013088 |
Spermatocele |
|
Ethinyl Estradiol |
3.46 | 16709447 |
MESH:D013119 |
Spinal Cord Injuries |
|
Progesterone |
3.80 | 15862959 16503802 |
MESH:D016135 |
Spinal Dysraphism |
|
sodium arsenite |
8.32 | 12854658 |
MESH:D016135 |
Spinal Dysraphism |
|
Valproic Acid |
8.32 | 19490988 |
OMIM:606688 |
SPONGIFORM ENCEPHALOPATHY WITH NEUROPSYCHIATRIC FEATURES |
marker/mechanism |
|
| |
MESH:D013226 |
Status Epilepticus |
|
Valproic Acid |
4.06 | 12833885 |
MESH:D013274 |
Stomach Neoplasms |
|
Benzene |
5.77 | 12562636 |
MESH:D013274 |
Stomach Neoplasms |
|
Cisplatin |
5.77 | 17522103 15958060 18396642 |
MESH:D013274 |
Stomach Neoplasms |
|
Diethylnitrosamine |
5.77 | 18456281 |
MESH:D013274 |
Stomach Neoplasms |
|
Fluorouracil |
5.77 | 16951190 19084572 19015929 15786421 17522103 18567086 18396642 17498489 16424979 17172411 |
MESH:D013274 |
Stomach Neoplasms |
|
nitrosobenzylmethylamine |
5.77 | 12958204 17575124 |
MESH:D019966 |
Substance-Related Disorders |
|
bisphenol A |
3.51 | 16045194 16684133 |
MESH:D015173 |
Supratentorial Neoplasms |
|
Vincristine |
5.40 | 12837982 |
MESH:D013733 |
Testicular Diseases |
|
Toluene |
4.48 | 10048760 10514026 |
MESH:D013736 |
Testicular Neoplasms |
|
Cisplatin |
4.19 | 17225452 15464296 |
MESH:D013921 |
Thrombocytopenia |
|
Lipopolysaccharides |
3.75 | 15821434 |
MESH:D019851 |
Thrombophilia |
|
Ethinyl Estradiol |
3.18 | 11994571 |
MESH:D013927 |
Thrombosis |
|
Ethinyl Estradiol |
2.75 | 15669648 |
MESH:D013953 |
Thymus Neoplasms |
|
Benzene |
4.48 | 10850423 |
MESH:D013959 |
Thyroid Diseases |
|
Tetrachlorodibenzodioxin |
3.42 | 12697716 |
MESH:D013964 |
Thyroid Neoplasms |
|
4,4'-diaminodiphenylmethane |
9.89 | 6582329 3712494 1399818 7505956 6587162 |
MESH:D013964 |
Thyroid Neoplasms |
|
Diethylnitrosamine |
9.89 | 7505956 |
MESH:D013964 |
Thyroid Neoplasms |
|
Doxorubicin |
9.89 | 16010429 17909728 |
MESH:D014062 |
Tongue Neoplasms |
|
Fluorouracil |
8.68 | 16280240 |
MESH:D014062 |
Tongue Neoplasms |
|
Zinc |
8.68 | 16543248 |
MESH:D014178 |
Translocation, Genetic |
|
Valproic Acid |
4.75 | 17262798 |
MESH:D020194 |
Unverricht-Lundborg Syndrome |
|
Valproic Acid |
4.04 | 3119515 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
4,4'-diaminodiphenylmethane |
10.25 | 8074119 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Cisplatin |
10.25 | 12973940 15464296 17225452 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Doxorubicin |
10.25 | 17653716 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
sodium arsenite |
10.25 | 17306315 16712894 16452187 11723127 |
MESH:D014564 |
Urogenital Abnormalities |
|
Valproic Acid |
4.18 | 8888407 |
MESH:D002583 |
Uterine Cervical Neoplasms |
|
Cisplatin |
13.54 | 16803524 |
MESH:D002583 |
Uterine Cervical Neoplasms |
|
Fluorouracil |
13.54 | 16803524 |
MESH:D002583 |
Uterine Cervical Neoplasms |
|
sodium arsenite |
13.54 | 11813266 |
MESH:D014591 |
Uterine Diseases |
|
bisphenol A |
4.52 | 14652134 |
MESH:D014594 |
Uterine Neoplasms |
|
Benzene |
8.07 | 12562636 |
MESH:D014594 |
Uterine Neoplasms |
|
Ethinyl Estradiol |
8.07 | 14692618 |
MESH:D014605 |
Uveitis |
|
Cyclosporine |
3.50 | 1336536 |
MESH:D014625 |
Vaginal Neoplasms |
|
Cisplatin |
4.15 | 15577323 |
MESH:D014652 |
Vascular Diseases |
|
sodium arsenite |
3.95 | 17056641 |
MESH:D054079 |
Vascular Malformations |
|
Tetrachlorodibenzodioxin |
4.11 | 12125929 |
MESH:D020246 |
Venous Thrombosis |
|
Ethinyl Estradiol |
3.11 | 14671159 15869587 |
MESH:D018487 |
Ventricular Dysfunction, Left |
|
Doxorubicin |
3.76 | 17334414 16364871 17678736 17638931 |
MESH:D014839 |
Vomiting |
|
Cisplatin |
4.23 | 11897121 |
MESH:D019282 |
Wasting Syndrome |
|
Tetrachlorodibenzodioxin |
3.76 | 15886252 |
MESH:D014985 |
Xerophthalmia |
|
Cyclosporine |
3.95 | 17120751 |